Furthermore, a significant reduction was observed in tumor volume and tumor weight in FOLFIRINOX-treated SAT1 knockdown cells compared to FOLFIRINOX treatment alone or SAT1 knockdown alone cohorts (Fig. 7 G–I). This evidence concerns the gene SAT1 and neoplasm.